Neogen Corporation (NEOG) has a MoatMap StockRank of 59/100 based on Quality (38/100), Value (33/100), and Momentum (73/100) factor scores. The current signal is HOLD. Neogen provides food and animal safety products. Once a high-quality compounder, the company has severely damaged its financial profile and ROIC through the poorly integrated merger with 3M's food safety division, leading to persistent operational headwinds and margin degradation.
Neogen Corporation develops and markets products dedicated to food and animal safety, including diagnostic test kits and genomic services. The company's diverse portfolio addresses critical needs in preventing food contamination and improving animal health and performance. Its global reach, strong R&D, and regulatory compliance position it as a leader in providing solutions for a safer food supply chain.
| Price | $9.29 |
| Market Cap | $2.0B |
| P/E (Forward) | 30.74 |
| Price/Book | 0.94 |
| Return on Equity | -25.6% |
| Return on Invested Capital | -32.5% |
| Debt/Equity | 37.82 |
| Gross Margin | 45.2% |
| Operating Margin | -1.6% |
| Revenue Growth | -4.4% |
| Free Cash Flow | $19M |
Neogen Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).